Islet Amyloid, Islet-Amyloid Polypeptide, and Diabetes Mellitus

New England Journal of Medicine

Volumn 321, Issue 8, 1989, Pages 513-518

  Epstein, Franklin H ^a   Johnson, Kenneth H ^b   O'brien, Timothy D ^b   Betsholtz, Christer ^c   Westermark, Per ^d  

^a University of Minnesota ^*

^b UNIVERSITY OF MINNESOTA   (United States)

^c UPPSALA UNIVERSITY   (Sweden)

^d LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLIN;

HISTOLOGY; HUMAN; HYALINE DEGENERATION; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET CELL; PRIORITY JOURNAL; REVIEW;

AMINO ACID SEQUENCE; AMYLOID; ANIMAL; DIABETES MELLITUS, NON-INSULIN-DEPENDENT; HUMAN; ISLETS OF LANGERHANS; MOLECULAR SEQUENCE DATA; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0024342752     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM198908243210806     Document Type: Review

References (46)

1. Westermark P, Wernstedt C. Wilander E, Sletten K. A novel peptide in the calcitonin gene related peptide family as an amyloid fibril protein in the endocrine pancreas. Biochem Biophys Res Commun 1986; 140: 827–31.
2. Westermark P, Wernstedt C, Wilander E, Hayden DW, O'Brien TD, Johnson KH. Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells. Proc Natl Acad Sci USA 1987; 84: 3881–5.
3. Westermark P, Wernstedt C, O'Brien TD, Hayden DW, Johnson KH. Islet amyloid in type 2 human diabetes mellitus and adult diabetic cats contains a novel putative polypeptide hormone. Am J Pathol 1987; 127: 414–7.
4. Bell ET. Hyalinization of the islets of Langerhans in diabetes mellitus. Diabetes 1952; 1: 341–4.
5. Ehrlich JC, Ratner JM. Amyloidosis of the islets of Langerhans: a restudy of islet hyalin in diabetic and nondiabetic individuals. Am J Pathol 1961; 38: 49–59.
6. Westermark P. Quantitative studies of amyloid in the islets of Langerhans. Ups J Med Sci 1972; 77: 91–4.
7. Westermark P, Grimelius L. The pancreatic islet cells in insular amyloidosis in human diabetic and non-diabetic adults. Acta Pathol Microbiol Scand [A] 1973; 81: 291–300.
8. Yano BL, Hayden DW, Johnson KH. Feline insular amyloid: association with diabetes mellitus. Vet Pathol 1981; 18: 621–7.
9. Johnson KH, Hayden DW, O'Brien TD, Westermark P. Spontaneous diabetes melhtus-islet amyloid complex in adult cats. Am J Pathol 1986; 125: 416–9.
10. Westermark P, Johnson KH. The pathogenesis of maturity-onset diabetes mellitus: is there a link to islet amyloid polypeptide? Bioessays 1988; 9: 30–3.
11. Betsholtz C, Svensson V, Rorsman F, et al. Islet amyloid polypeptide (IAPP): cDNA cloning and identification of an amyloidogenic region associated with the species-specific occurrence of age-related diabetes mellitus. Exp Cell Res (in press).
12. Opie EL. On the relation of chronic interstitial pancreatitis to the islands of Langerhans and to diabetes mellitus. J Exp Med 1900; 5: 397–428.
13. Westermark P. Fine structure of islets of Langerhans in insular amyloidosis. Virchows Arch [A] 1973; 359: 1–18.
14. Lacy PE. Electron microscopy of the beta cell of the pancreas. Am J Med 1961; 31: 851–9.
15. Johnson KH, Stevens JB. Light and electron microscopic studies of islet amyloid in diabetic cats. Diabetes 1973; 22: 81–90.
16. Yano BL, Hayden DW, Johnson KH. Feline insular amyloid: ultrastructural evidence for intracellular formation by nonendocrine cells. Lab Invest 1981; 45: 149–56.
17. Bell ET. Hvalinization of the islets of Langerhans in nondiabetic individuals. Am J Pathol 1959; 35: 801–5.
18. Howard CF Jr. Insular amyloidosis and diabetes mellitus in Macaca nigra. Diabetes 1978; 27: 357–64.
19. Westermark P. Amyloid of human islets of Langerhans. 1. Isolation and some characteristics. Acta Pathol Microbiol Scand [C] 1975; 83: 439–46.
20. Westermark. On the nature of the amyloid in human islets of Langerhans. Histochemistry 1974; 38: 27–33.
21. Comwell GG III, Natvig JB, Westermark P, Husby G. Senile cardiac amyloid: demonstration of a unique fibril protein in tissue sections. J Immunol 1978; 120: 1385–8.
22. Westermark P. The nature of amyloid in islets of Langerhans in old age. In: Wegelius O, Pasternack A, eds. Amyloidosis. New York: Academic Press, 1976:533–41.
23. Clark A, Holman RR, Matthews DR, Hockaday TD, Turner RC. Non-uniform distribution of islet amyloid in the pancreas of “maturity-onset” diabetic patients. Diabetologia 1984; 27: 527–8.
24. Sletten K, Westermark P, Natvig JB. Characterization of amyloid fibril proteins from medullary carcinoma of the thyroid. J Exp Med 1976; 143: 993–8.
25. Cooper GJ, Willis achéal, Clark A, Turner RC, Sim RB, Reid KB. Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients. Proc Natl Acad Sci USA 1987; 84: 8628–32.
26. Cooper GJ, Leighton B, Dimitriadis GD, et al. Amylin found in amyloid deposits in human type 2 diabetes mellitus may be a hormone that regulates glycogen metabolism in skeletal muscle. Proc Natl Acad Sci USA 1988; 85: 7763–6.
27. Leighton B, Cooper GJ. Pancreatic amylin and calcitonin gene-related peptide cause resistance to insulin in skeletal muscle in vitro. Nature 1988; 335: 632–5.
28. Amara SG, Jonas V, Rosenfeld MG, Ong ES, Evans RM. Alternative RNA processing in calcitonin gene expression generates mRNAs encoding different polypeptide products. Nature 1982; 298: 240–4.
29. Steenbergh PH, Höppener JW, Zandberg J, Lips CJ, Jansz HS. A second human calcitonin/CGRP gene. FEBS Lett 1985; 183: 403–7.
30. Westermark P, Wilander E, Westermark GT, Johnson KH. Islet amyloid polypeptide-like immunoreactivity in the islet B cells of type 2 (non-insulin-dependent) diabetic and non-diabetic individuals. Diabetologia 1987; 30: 887–92.
31. Johnson KH, O'Brien TD, Hayden DW, et al. Immunolocalization of islet amyloid polypeptide (IAPP) in pancreatic beta cells by means of peroxidase–antiperoxidase (PAP) and protein A-gold techniques. Am J Pathol 1988; 130: 1–8.
32. Cooper GJS, Willis achéal, Reid KBM, et al. Diabetes-associated peptide. Lancet 1987; 2: 966.
33. Johnson KH, O'Brien TD, Hayden DW, Mahoney WC, Wernstedt C, Westermark P. Relationships of islet amyloid polypeptide (IAPP) to spontaneous diabetes in adult cats. In: Isobe T, Araki S, Uchino F, Kito S, Tsubura E, eds. Amyloid and amyloidosis. New York: Plenum Press, 1988:673–8.
34. Lukinius A, Wilander E, Westermark GT, Engström U, Westermark P. Co-localization of islet amyloid polypeptide and insulin in the B cell secretory granules of the human pancreatic islets. Diabetologia 1989; 32: 240–4.
35. Sanke T, Bell GI, Sample C, Rubenstein AH, Steiner DF. An islet amyloid polypeptide is derived from an 89-amino acid precursor by proteolytic processing. J Biol Chem 1988; 263: 17243–6.
36. Bradbury AF, Finnie MD, Smyth DG. Mechanisms of C-terminal amide formation by pituitary enzymes. Nature 1982; 298: 686–8.
37. Mosselman S, Höppener JW, Zandberg J, et al. Islet amyloid polypeptide: identification and chromosomal localization of the human gene. FEBS Lett 1988; 239: 227–32.
38. Craig SP, Buckle VJ, Lamouroux A, Mallet J, Craig I. Localization of the human tyrosine hydroxylase gene to 11pl5: gene duplication and evolution of metabolic pathways. Cytogenet Cell Genet 1986; 42: 29–32.
39. Glenner GG. Amyloid deposits and amyloidosis: the β-fibrilloses. N Engl J Med 1980; 302: 1283–92, 1333–43.
40. Glenner GG, Eanes ED, Wiley CA. Amyloid fibrils formed from a segment of the pancreatic islet amyloid protein. Biochem Biophys Res Commun 1988; 155: 608–14.
41. Westermark P, Wilander E. The influence of amyloid deposits on the islet volume in maturity onset diabetes mellitus. Diabetologia 1978; 15: 417–21.
42. O'Brien TD, Hayden DW, Johnson KH, Fletcher TF. Immunohistochemical motphometry of pancreatic endocrine cells in diabetic, normoglycaemic glucose-intolerant and normal cats. J Comp Pathol 1986; 96: 357–69.
43. Clark A, Cooper GJS, Lewis CE, et al. Islet amyloid formed from diabetesassociated peptide may be pathogenic in type-2 diabetes. Lancet 1987; 2: 231–4.
44. Modifications of glucose storage and oxidation in nonobese diabetics, measured by continuous indirect calorimetry, H.U., Meyer, B., Curchod, E., Maeder, P., Pahud, E., Jéquier, J.P., Felber, Diabetes, (1980), 29, 752-756
45. Felber JP, Meyer HU, Curchod B, et al. Glucose storage and oxidation in different degrees of human obesity measured by continuous indirect calorimetry. Diabetologia 1981; 20: 39–44.
46. Johnson KH, O'Brien TD, Jordan K, Westermark P. Impaired glucose tolerance is associated with increased islet amyloid polypeptide (IAPP) immunoreactivity in pancreatic beta cells. Am J Pathol 1989; 135: 245–50.